207 related articles for article (PubMed ID: 17383993)
1. Effects of intravitreal triamcinolone acetonide injection with and without preservative.
Maia M; Farah ME; Belfort RN; Penha FM; Lima Filho AA; Aggio FB; Belfort R
Br J Ophthalmol; 2007 Sep; 91(9):1122-4. PubMed ID: 17383993
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006.
Stepien KE; Eaton AM; Jaffe GJ; Davis JL; Raja J; Feuer W
Retina; 2009 Feb; 29(2):207-13. PubMed ID: 19050670
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
4. Effects of triamcinolone acetonide injections with and without preservative.
Jonas JB
Br J Ophthalmol; 2007 Sep; 91(9):1099-101. PubMed ID: 17709575
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
[TBL] [Abstract][Full Text] [Related]
6. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
7. Sterile endophthalmitis following intravitreal injection of triamcinolone acetonide.
Wang LC; Yang CM
Ocul Immunol Inflamm; 2005; 13(4):295-300. PubMed ID: 16159720
[TBL] [Abstract][Full Text] [Related]
8. Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema.
Moshfeghi AA; Scott IU; Flynn HW; Puliafito CA
Am J Ophthalmol; 2004 Sep; 138(3):489-92. PubMed ID: 15364241
[TBL] [Abstract][Full Text] [Related]
9. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection.
Nelson ML; Tennant MT; Sivalingam A; Regillo CD; Belmont JB; Martidis A
Retina; 2003 Oct; 23(5):686-91. PubMed ID: 14574256
[TBL] [Abstract][Full Text] [Related]
10. Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone.
Yoon SJ; Rhee DY; Marx JL; Blaha GR; Rogers AH; Baumal CR; Reichel E; Duker JS
Am J Ophthalmol; 2009 Jun; 147(6):1031-6. PubMed ID: 19268893
[TBL] [Abstract][Full Text] [Related]
11. Short-term complications of intravitreal injection of triamcinolone acetonide.
Roth DB; Realini T; Feuer WJ; Radhakrishnan R; Gloth J; Heimmel MR; Fechtner RD; Yarian DL; Green SN
Retina; 2008 Jan; 28(1):66-70. PubMed ID: 18185140
[TBL] [Abstract][Full Text] [Related]
12. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
Jonas JB; Kreissig I; Spandau UH; Harder B
Am J Ophthalmol; 2006 Mar; 141(3):579-80. PubMed ID: 16490517
[TBL] [Abstract][Full Text] [Related]
13. Complications of intravitreal injection of triamcinolone acetonide.
Ozkiriş A; Erkiliç K
Can J Ophthalmol; 2005 Feb; 40(1):63-8. PubMed ID: 15825532
[TBL] [Abstract][Full Text] [Related]
14. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG
Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
[TBL] [Abstract][Full Text] [Related]
15. Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide.
Jonisch J; Lai JC; Deramo VA; Flug AJ; Fastenberg DM
Br J Ophthalmol; 2008 Aug; 92(8):1051-4. PubMed ID: 18653598
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
18. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
[TBL] [Abstract][Full Text] [Related]
19. Frequency and management of raised intraocular pressure following intravitreal triamcinolone acetonide.
Mahar PS; Memon AS
J Coll Physicians Surg Pak; 2012 Nov; 22(11):699-702. PubMed ID: 23146849
[TBL] [Abstract][Full Text] [Related]
20. The effect of intravitreal triamcinolone acetonide on intraocular pressure.
Bakri SJ; Beer PM
Ophthalmic Surg Lasers Imaging; 2003; 34(5):386-90. PubMed ID: 14509462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
